Argo Securities confirms "buy" on Norwegian DiaGenic on distribution deal

Submit press release

Existing customer?
Log in

New customer?
Sign up

Latest Headlines
Research and Markets: The Report 'PV Innovation in North America'...
Research and Markets: Vietnam Telecommunications Services Market Report:...
Research and Markets: Indonesia Soft Drinks Review 2011: consumption,...
Northampton family thank Red Cross with generous donation to county...
Research and Markets: Malaysia Soft Drinks Review 2011: consumption,...
Simon Ward - The MPC is making another policy...

M2 Archive: Preview

You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.

Argo Securities confirms "buy" on Norwegian DiaGenic on distribution deal
21 January 2010 - Argo Securities reiterated yesterday its "buy" recommendation on Norwegian biotechnology company DiaGenic ASA (OSL: DIAG), following the distribution deal with Spanish pharma company Grupo Ferrer.
DiaGenic said on Wednesday it signed an agreement for the exclusive...

If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search